Ardent Health Hit With Multiple Securities Suits Over Receivables as Lead‑Plaintiff Deadline Nears March 9

Plaintiffs cite disclosures showing a $43 million revenue cut with a $54 million reserve jump after a shift to a new receivables system.

Overview

Complaints are pending in the U.S. District Court for the Middle District of Tennessee, including Postiwala v. Ardent Health, Inc., No. 3:26-cv-00022.
The proposed class period runs from July 18, 2024 to Nov. 12, 2025, and motions to be appointed lead plaintiff are due March 9, 2026.
Filings by Hagens Berman, Rosen Law, Pomerantz, Kahn Swick & Foti, and Bleichmar Fonti & Auld allege misleading statements about accounts receivable collectability and timely write‑offs.
Plaintiffs reference company remarks that it relied on detailed hindsight analyses even as a 180‑day cliff governed prior reserves, with the new Kodiak RCA system recognizing reserves earlier.
Law firm notices also note Ardent’s guidance reduction of about $57.5 million and a roughly 33% share‑price drop on Nov. 13, 2025, while urging investor and whistleblower contacts.